ATAI Life Sciences N.V.
BTC Holdings
58
Total P&L
+35.11%
Total profit/loss on Bitcoin holdings
Average Cost per BTC
$86,207
Average price paid for each Bitcoin
Share Price
$4.16
Current trading price per share
Market Cap
$881M
Total market capitalization
Enterprise Value
$770M
Market cap plus debt minus cash
NAV Multiple
130.479
Net Asset Value multiplier
BTC / Market Cap
0.8%
Bitcoin holdings as % of market cap
About ATAI Life Sciences N.V.
ATAI Life Sciences N.V., listed on Nasdaq with the ticker ATAI, is a clinical-stage biopharmaceutical company headquartered in Berlin, Germany. Founded in 2018, it emerged to address unmet needs in mental health through innovative therapies. Its business model centers on a decentralized platform that incubates and advances psychedelic-inspired compounds and digital therapeutics. Core operations involve developing treatments for disorders like depression, anxiety, and addiction, leveraging partnerships with subsidiaries to accelerate research, clinical trials, and regulatory pathways.
The company integrates Bitcoin into its treasury strategy, holding it as a reserve asset to diversify its financial portfolio and hedge against inflation. This reflects a forward-thinking approach to corporate finance amid economic uncertainties. Beyond treasury management, ATAI explores broader digital asset strategies, including potential blockchain applications for secure data handling in clinical research and patient privacy, aligning with its mission to innovate in healthcare delivery.
Led by CEO Florian Brand and Chairman Christian Angermayer, a visionary in biotech and finance, ATAI maintains a prominent industry presence with a robust pipeline of psychedelic therapies. Its leadership drives collaboration across academia and industry, positioning ATAI as a leader in mental health innovation. By combining cutting-edge science with strategic financial tools, ATAI ensures long-term relevance in transforming global healthcare.
Recent Developments
- Mar 31, 2025: Bitcoin holdings increased by 58.00 BTC to 58 BTC with cost basis of $5M (BTC @ $82.4K), stock price $1.47
ATAI Life Sciences N.V. β Bitcoin Holdings Over Time
1y - Present
Loading holdings data...
ATAI Life Sciences N.V. β Stock vs BTC Dynamics
1y - Present
Loading stock data...
Balance Sheet History